Yahoo
LSE - Delayed Quote GBp

Shield Therapeutics plc (STX.L)

5.16 -0.92 (-15.13%)
As of 3:55:02 PM GMT+1. Market Open.
View in AlphaSpace Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
58,625
49,701
32,180
13,085
5,499
Cost of Revenue
28,057
26,662
17,250
9,058
3,041
Gross Profit
30,568
23,039
14,930
4,027
2,458
Operating Expense
34,618
33,089
37,803
35,358
34,104
Operating Income
-4,050
-10,050
-22,873
-31,331
-31,646
Net Non Operating Interest Income Expense
-6,004
-7,327
-3,607
-501
-442
Pretax Income
-9,818
-17,141
-26,556
-32,375
-49,343
Tax Provision
555
514
626
918
446
Net Income Common Stockholders
-10,373
-17,655
-27,182
-33,293
-49,789
Diluted NI Available to Com Stockholders
-10,373
-17,655
-27,182
-33,293
-49,789
Basic EPS
-0.01
--
-0.03
-0.05
-0.21
Diluted EPS
-0.01
--
-0.03
-0.05
-0.21
Basic Average Shares
1,060,883.97
--
906,066.67
665,860
237,905.88
Diluted Average Shares
1,060,883.97
--
906,066.67
665,860
237,905.88
Total Operating Income as Reported
-4,050
-10,050
-22,873
-31,331
-49,752
Rent Expense Supplemental
--
--
--
--
147.64
Total Expenses
62,675
59,751
55,053
44,416
37,145
Net Income from Continuing & Discontinued Operation
-10,373
-17,655
-27,182
-33,293
-49,789
Normalized Income
-10,479.80
-17,788.50
-27,182
-33,293
-35,123.14
Interest Income
-68
91
266
518
37
Interest Expense
5,933
7,415
3,873
1,016
403
Net Interest Income
-6,004
-7,327
-3,607
-501
-442
EBIT
-3,885
-9,726
-22,683
-31,359
-48,940
EBITDA
-2,998
-8,611
-21,258
-30,288
-46,067
Reconciled Cost of Revenue
28,057
26,662
17,250
9,058
3,041
Reconciled Depreciation
886
1,115
1,425
1,071
2,662
Net Income from Continuing Operation Net Minority Interest
-10,373
-17,655
-27,182
-33,293
-49,789
Total Unusual Items Excluding Goodwill
178
178
0
0
-18,106
Total Unusual Items
178
178
0
0
-18,106
Normalized EBITDA
-3,176
-8,789
-21,258
-30,288
-27,961
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
71.20
44.50
0
0
-3,440.14
12/31/2022 - 2/26/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: